cbdMD shares surge 13.33% premarket as investors anticipate upcoming earnings report and potential guidance update.

cbdMD surged 13.33% in premarket trading ahead of its scheduled quarterly earnings report on February 17, 2026. Analysts expect the company to report an EPS of $-0.06, but the market is anticipating results that could surpass estimates or include positive forward guidance. The premarket rally reflects investor optimism about potential earnings surprises or strategic updates that could signal improved performance or growth prospects. Recent news highlighted the importance of earnings guidance as a key driver for cbdMD’s stock, with the company’s past focus on cost management and operational improvements potentially supporting a positive report. While older news items, such as product launches or partnerships, are present, they are not directly linked to the immediate premarket move. The timing aligns with the earnings event as the primary catalyst.